618 related articles for article (PubMed ID: 9855424)
1. Mucosal responses to parenteral and mucosal vaccines.
Kaul D; Ogra PL
Dev Biol Stand; 1998; 95():141-6. PubMed ID: 9855424
[TBL] [Abstract][Full Text] [Related]
2. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.
Herremans TM; Reimerink JH; Buisman AM; Kimman TG; Koopmans MP
J Immunol; 1999 Apr; 162(8):5011-8. PubMed ID: 10202050
[TBL] [Abstract][Full Text] [Related]
3. Immunologic and virologic aspects of secretory immune system in human respiratory tract.
Ogra PL; Morag A
Dev Biol Stand; 1975; 28():129-44. PubMed ID: 47823
[TBL] [Abstract][Full Text] [Related]
4. Anomalous observations on IPV and OPV vaccination.
John TJ
Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
[TBL] [Abstract][Full Text] [Related]
5. Vaccination by non-parenteral routes: characteristics of immune response.
Ogra PL; Chiba Y; Beutner KR; Morag A
Dev Biol Stand; 1976; 33():19-26. PubMed ID: 782968
[TBL] [Abstract][Full Text] [Related]
6. Mucosal microenvironment and mucosal response.
Abraham R; Ogra PL
Am J Trop Med Hyg; 1994; 50(5 Suppl):3-9. PubMed ID: 8203721
[TBL] [Abstract][Full Text] [Related]
7. New perspectives in vaccine development: mucosal immunity to infections.
McGhee JR; Kiyono H
Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356
[TBL] [Abstract][Full Text] [Related]
8. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
[TBL] [Abstract][Full Text] [Related]
9. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.
Mestecky J; Michalek SM; Moldoveanu Z; Russell MW
Behring Inst Mitt; 1997 Feb; (98):33-43. PubMed ID: 9382757
[TBL] [Abstract][Full Text] [Related]
10. Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge.
Morrison LA; Da Costa XJ; Knipe DM
Virology; 1998 Mar; 243(1):178-87. PubMed ID: 9527927
[TBL] [Abstract][Full Text] [Related]
11. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
[TBL] [Abstract][Full Text] [Related]
12. [The development of mucosal vaccines].
Bakke H; Haneberg B
Tidsskr Nor Laegeforen; 2006 Nov; 126(21):2818-21. PubMed ID: 17086224
[TBL] [Abstract][Full Text] [Related]
13. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T
Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173
[TBL] [Abstract][Full Text] [Related]
14. Mucosal immunity: implications for vaccine development.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Immunobiology; 1992 Feb; 184(2-3):157-79. PubMed ID: 1587541
[TBL] [Abstract][Full Text] [Related]
15. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
16. The immune response to influenza vaccines.
Ghendon Y
Acta Virol; 1990 May; 34(3):295-304. PubMed ID: 1980401
[TBL] [Abstract][Full Text] [Related]
17. Vaccination against acute respiratory virus infections and measles in man.
Osterhaus AD; de Vries P
Immunobiology; 1992 Feb; 184(2-3):180-92. PubMed ID: 1587542
[TBL] [Abstract][Full Text] [Related]
18. Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.
Bessa J; Schmitz N; Hinton HJ; Schwarz K; Jegerlehner A; Bachmann MF
Eur J Immunol; 2008 Jan; 38(1):114-26. PubMed ID: 18081037
[TBL] [Abstract][Full Text] [Related]
19. Systemic and mucosal immunity induced by oral somatic transgene vaccination against glycoprotein B of pseudorabies virus using live attenuated Salmonella typhimurium.
Eo SK; Yoon HA; Aleyas AG; Park SO; Han YW; Chae JS; Lee JH; Song HJ; Cho JG
FEMS Immunol Med Microbiol; 2006 Aug; 47(3):451-61. PubMed ID: 16872383
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
Wang X; Zhang X; Kang Y; Jin H; Du X; Zhao G; Yu Y; Li J; Su B; Huang C; Wang B
Vaccine; 2008 Sep; 26(40):5135-44. PubMed ID: 18462848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
